ACG: Digital Risk Assessment Tool Can ID Risk of Cancer Susceptibility Syndromes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 26, 2023 -- Implementation of a digital risk assessment tool can identify patients with high-risk cancer susceptibility syndromes, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 20 to 25 in Vancouver, Canada.
Heather Hampel, from the City of Hope National Medical Center in Duarte, California, and colleagues examined implementation of a digital cancer risk assessment tool and genetic testing program in gastroenterology practices. Seven practices of 17 gastrointestinal providers implemented the service between September 2021 and May 2023.
Overall, 5,830 of 9,340 assessment invitations were completed out of 25,349 patient appointments. The researchers found that 25.2 percent of the invitations completed met the National Comprehensive Cancer Network criteria for genetic counseling and testing; 27.4 percent had genetic testing ordered and 74.9 percent completed testing. Overall, 15.6 percent of those tested were found to have 49 pathogenic/likely pathogenic variants (P/LPVs) in a cancer susceptibility gene, while 23.5 and 61.3 percent had variants of uncertain significance and tested negative, respectively. Twelve individuals were diagnosed with high-risk cancer susceptibility syndromes: seven, four, and one with Lynch syndrome, hereditary breast-ovarian cancer syndrome, and Li Fraumeni syndrome, respectively. Thirteen individuals had P/LPVs in moderate-risk genes; 24 individuals carried autosomal recessive disorders that did not affect their cancer risk but were important for reproductive risk counseling.
"Patients should possess awareness and knowledge regarding hereditary genetic cancer predispositions, as well as the significance of undergoing suitable genetic screening and counseling for themselves and their families," presenting author Daniel J. Pambianco, M.D., of Gastro Health in Charlottesville, Virginia, said in a statement. "Numerous cancers and conditions of this nature can either be prevented or identified in their early stages."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
First Responders With More Debris Exposure Have Higher Risk of Early Dementia
FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...
1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...
Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy
FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.